RxDoctor Payments Data

David Steckman, MD

Clinical Cardiac Electrophysiology · Poughkeepsie, NYNPI 1043466832

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $3,011 of the $3,546 with a category attached, or 84.9%. 6 manufacturers reported payments, led by Abbott at 31.1% of the total. That places this record below the midpoint for clinical cardiac electrophysiology clinicians in NY, where the typical reported total is $18,433.

$3,546in general payments, 2019–2025

Across 70 payments — averaging $50.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$1K
  • Boston Scientific$817
  • Medtronic$762
  • Biosense Webster, Inc.$680
  • Abiomed$140
  • Edwards Lifesciences$43
$36,189in research payments, 2019–2025

Across 14 payments — averaging $2584.93 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Boston Scientific$20K
  • Medical Device Business Services, Inc.$15K
  • Abbott$1K

What the payments were for

  • Travel & lodging$53515%
  • Food & beverage$3,01185%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Abbott14$1,104
Boston Scientific13$817
Medtronic(2 entities)14$762
Biosense Webster, Inc.21$680
Abiomed5$140
Edwards Lifesciences3$43

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,546 in reported general payments places this provider in the 15th percentile of 214 clinical cardiac electrophysiology providers in New York.

See all clinical cardiac electrophysiology providers in New York →

Medicare billing

Part B allowed, 2024
$463,540
Medicare patients
1,498
Services billed
4,047

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban239$300,361
Dofetilide231$116,674
XareltoRivaroxaban61$72,773
Amiodarone Hcl185$11,995
Dabigatran EtexilateDabigatran Etexilate Mesylate15$4,930
Flecainide Acetate91$4,267
Metoprolol Succinate198$3,000
SotalolSotalol Hcl36$1,000
Diltiazem 24hr Er (Cd)Diltiazem Hcl32$999
Metoprolol Tartrate70$412
Doxycycline Monohydrate40$227
Pantoprazole Sodium29$138
Carvedilol17$133
Amlodipine Besylate12$97
Furosemide15$37

Paid to pharmacies, not to this prescriber.

Other clinical cardiac electrophysiology in Poughkeepsie

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →